1. Patients with Obesity Should be Recognised as a Special Patient Population During Drug Development of Antibacterial and Antifungal Agents; A Call to Action

   • K. P. van Rhee
   • C. A. J. Knibbe
   • R. J. M. Brüggemann

   Current Opinion Open access 05 January 2024 Pages: 1 - 12

   

2. Preclinical Pharmacokinetic/Pharmacodynamic Studies and Clinical Trials in the Drug Development Process of EMA-Approved Antifungal Agents: A Review

   • Theresa Pecho
   • Markus Zeitlinger

   Review Article Open access 16 November 2023 Pages: 13 - 26

   

3. A Comprehensive Review of the Clinical Pharmacokinetics, Pharmacodynamics, and Drug Interactions of Nirmatrelvir/Ritonavir

   • Jacqueline Gerhart
   • Donna S. Cox
   • Bharat Damle

   Review Article Open access 04 January 2024 Pages: 27 - 42

   

4. Interplay of UDP-Glucuronosyltransferase and CYP2C8 for CYP2C8 Mediated Drug Oxidation and Its Impact on Drug–Drug Interaction Produced by Standardized CYP2C8 Inhibitors, Clopidogrel and Gemfibrozil

   • Katsumi Iga
   • Akiko Kiriyama

   Original Research Article 03 November 2023 Pages: 43 - 56

   

5. Pharmacokinetics, Safety, and Tolerability of Anti-SARS-CoV-2 Monoclonal Antibody, Sotrovimab, Delivered Intravenously or Intramuscularly in Japanese and Caucasian Healthy Volunteers

   • Ahmed Nader
   • Elizabeth Alexander
   • Daren Austin

   Original Research Article Open access 13 November 2023 Pages: 57 - 68

   

6. Development of a Generic Fetal Physiologically Based Pharmacokinetic Model and Prediction of Human Maternal and Fetal Organ Concentrations of Cefuroxime

   • Xiaomei I. Liu
   • Dionna J. Green
   • André Dallmann

   Original Research Article 14 November 2023 Pages: 69 - 78

   

7. How to Dose Vancomycin in Overweight and Obese Patients with Varying Renal (Dys)function in the Novel Era of AUC 400–600 mg·h/L-Targeted Dosing

   • Tan Zhang
   • Elke H. J. Krekels
   • Catherijne A. J. Knibbe

   Original Research Article Open access 16 November 2023 Pages: 79 - 91

   

8. Population Pharmacokinetic/Pharmacodynamic Analysis of the Glucokinase Activator PB201 in Healthy Volunteers and Patients with Type 2 Diabetes Mellitus: Facilitating the Clinical Development of PB201 in China

   • Ling Song
   • Fangrui Cao
   • Dongyang Liu

   Original Research Article 20 November 2023 Pages: 93 - 108

   

9. Digoxin Pharmacokinetics in Patients with Obesity Before and After a Gastric Bypass or a Strict Diet Compared with Normal Weight Individuals

   • Kine Eide Kvitne
   • Markus Hovd
   • Ida Robertsen

   Original Research Article Open access 22 November 2023 Pages: 109 - 120

   

10. Impact of Key Components of Intensified Ceftaroline Dosing on Pharmacokinetic/Pharmacodynamic Target Attainment

    • Iris K. Minichmayr
    • Sebastian G. Wicha
    • Markus Zeitlinger

    Original Research Article Open access 26 November 2023 Pages: 121 - 131